ABN AMRO Bank’s Teva Pharmaceuticals TEVA Stock Holding History

ABN AMRO Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,300	Closed	-$281K	–	165
2025 Q1	$281K	Hold	18,300	–	–	﹤0.01%	151
2024 Q4	$399K	Hold	18,300	–	–	0.01%	150
2024 Q3	$328K	Hold	18,300	–	–	﹤0.01%	146
2024 Q2	$300K	Hold	18,300	–	–	﹤0.01%	143
2024 Q1	$258K	Hold	18,300	–	–	﹤0.01%	147
2023 Q4	$192K	Hold	18,300	–	–	﹤0.01%	155
2023 Q3	$187K	Hold	18,300	–	–	﹤0.01%	152
2023 Q2	$138K	Hold	18,300	–	–	﹤0.01%	152
2023 Q1	$163K	Buy	+18,300	New	+$181K	﹤0.01%	143

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

ABN AMRO Bank's TEVA Position: Q2 2025 in Review

ABN AMRO Bank sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 18,300 shares — an estimated $281K sold.

ABN AMRO Bank first reported a position in TEVA in Q1 2023 and held it in 9 quarters. The position peaked at $399K in Q4 2024. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

ABN AMRO Bank reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
ABN AMRO Bank sold 18,300 Teva Pharmaceuticals shares in Q2 2025, an estimated $281K.
ABN AMRO Bank first reported a position in Teva Pharmaceuticals in Q1 2023 and held it in 9 quarters.
ABN AMRO Bank's Teva Pharmaceuticals position peaked at $399K in Q4 2024.
539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on ABN AMRO Bank's 13F filing for Q2 2025, filed 12 Aug 2025.